Literature DB >> 15145576

p53's double life: transactivation-independent repression of homologous recombination.

Pascale Bertrand1, Yannick Saintigny, Bernard S Lopez.   

Abstract

The tumor suppressor protein p53 controls cell cycle checkpoints and apoptosis via the transactivation of several genes. However, data from various laboratories suggest an additional role for p53: transcription-independent suppression of homologous recombination (HR). Genetic and physical interactions among p53, HR proteins (e.g. RAD51 and RAD54) and HR-DNA intermediates show that p53 acts directly on HR during the early and late steps of recombination. Complementary to the MSH2 mismatch-repair system, p53 appears to impair excess HR by controlling the minimal efficiency processing segment and by reversing recombination intermediates. By controlling the balance between the BLM and the RAD51 pathways, this direct role of p53 could maintain genome stability when replication forks are stalled at regions of DNA damage. In this article, we discuss the direct role of p53 on HR and the consequences for genome stability, tumor protection and speciation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15145576     DOI: 10.1016/j.tig.2004.04.003

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  46 in total

1.  Initiation of DNA double strand break repair: signaling and single-stranded resection dictate the choice between homologous recombination, non-homologous end-joining and alternative end-joining.

Authors:  Anastazja Grabarz; Aurélia Barascu; Josée Guirouilh-Barbat; Bernard S Lopez
Journal:  Am J Cancer Res       Date:  2012-04-21       Impact factor: 6.166

2.  Mapping the physical and functional interactions between the tumor suppressors p53 and BRCA2.

Authors:  Sridharan Rajagopalan; Antonina Andreeva; Trevor J Rutherford; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

Review 3.  The ubiquitin/26S proteasome system in plant-pathogen interactions: a never-ending hide-and-seek game.

Authors:  Anne-Sophie Dielen; Saloua Badaoui; Thierry Candresse; Sylvie German-Retana
Journal:  Mol Plant Pathol       Date:  2010-03       Impact factor: 5.663

4.  Discriminatory suppression of homologous recombination by p53.

Authors:  Sheng Yun; Chadwick Lie-A-Cheong; Andrew C G Porter
Journal:  Nucleic Acids Res       Date:  2004-12-15       Impact factor: 16.971

Review 5.  Transcriptional regulation by p53.

Authors:  Rachel Beckerman; Carol Prives
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-28       Impact factor: 10.005

6.  DNA damage tolerance pathway involving DNA polymerase ι and the tumor suppressor p53 regulates DNA replication fork progression.

Authors:  Stephanie Hampp; Tina Kiessling; Kerstin Buechle; Sabrina F Mansilla; Jürgen Thomale; Melanie Rall; Jinwoo Ahn; Helmut Pospiech; Vanesa Gottifredi; Lisa Wiesmüller
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-12       Impact factor: 11.205

7.  Control of translocations between highly diverged genes by Sgs1, the Saccharomyces cerevisiae homolog of the Bloom's syndrome protein.

Authors:  Kristina H Schmidt; Joann Wu; Richard D Kolodner
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

8.  DNA damage response to the Mdm2 inhibitor nutlin-3.

Authors:  Rajeev Verma; Marc J Rigatti; Glenn S Belinsky; Cassandra A Godman; Charles Giardina
Journal:  Biochem Pharmacol       Date:  2010-02-15       Impact factor: 5.858

Review 9.  Palindromic gene amplification--an evolutionarily conserved role for DNA inverted repeats in the genome.

Authors:  Hisashi Tanaka; Meng-Chao Yao
Journal:  Nat Rev Cancer       Date:  2009-02-12       Impact factor: 60.716

10.  The transcriptional regulatory function of p53 is essential for suppression of mouse skin carcinogenesis and can be dissociated from effects on TGF-beta-mediated growth regulation.

Authors:  Roshini M Ponnamperuma; Kathryn E King; Tamador Elsir; Adam B Glick; Geoffrey M Wahl; Monica Nister; Wendy C Weinberg
Journal:  J Pathol       Date:  2009-10       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.